Schedule 13G ownership disclosure
Terns Pharmaceuticals Inc
Common Stock, $0.0001 par value per share · CUSIP: 880881107
Event date: 2025-09-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Commodore Capital LP
Shares: 4,650,000.00 · Class: 5.3%
- Commodore Capital Master LP
Shares: 4,650,000.00 · Class: 5.3%
- Robert Egen Atkinson
Shares: 4,650,000.00 · Class: 5.3%
- Michael Kramarz
Shares: 4,650,000.00 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001831942-25-000019
- Form type
- SCHEDULE 13G
- Filer
- Commodore Capital LP
- CIK
- CIK 1831942
- Filed
- Sep 16, 2025
- Reporting period
- Sep 09, 2025
- Description
- Schedule 13G beneficial ownership